Benzinga | Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals

Market Overview

0.0000 0 (%)

Data as of May 26, 2019

Prev. Close
Price Open
Volume 0
Day's Range -
52 Wk Range -
50 Day Moving Avg.
PE Ratio
Shares Outstanding
Market Cap

Trade EDT stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

Financial Breakfast: Morning News Summary for June 4, 2012 Brandon PilznerMon, 04 Jun 2012 07:25:43 -0400
Transocean Launches Unconditional Offer for Shares of Aker Drilling Eddie StaleyFri, 26 Aug 2011 06:54:15 -0400
Oilsands Quest Inc. Extends Rights Offering Subscription Period Allie WickmanWed, 10 Aug 2011 08:01:24 -0400
Bank of America Expects Greater Earnings on Alkemes Inc. from Approval of Bydureon, Mantains Buy Bo WangThu, 23 Jun 2011 18:52:08 -0400
UPDATE: Hapoalim Raising Price Target On Alkermes (ALKS) Jonathan ChenMon, 09 May 2011 12:38:37 -0400
{{ story.title }} {{ story.author }}{{ story.created }}

NCR Announces Strong First-Quarter Results Benzinga StaffApr 19, 2012
Sprint Gives Customers Incentives to Go Green on Earth Day Benzinga StaffApr 19, 2012
Sprint Gives Customers Incentives to Go Green on Earth Day Benzinga StaffApr 19, 2012
Staples.com Survey Reveals Businesses Can Manage Without the Boss, But Not the Office Administrator Benzinga StaffApr 19, 2012
Webcast Alert: Heska Corporation's Annual Meeting of Stockholders Webcast PRWebApr 19, 2012
Syntel Reports First Quarter 2012 Financial Results Benzinga StaffApr 19, 2012
Boston Scientific Announces First Quarter 2012 Results PRWebApr 19, 2012
Maxwell Technologies to Report First Quarter Financial Results on April 26; Annual Stockholders Meeting Set for May 9 PRWebApr 19, 2012
Nexon to Release First Quarter 2012 Financial Results Benzinga StaffApr 19, 2012
Crown Holdings Reports First Quarter 2012 Results PRWebApr 18, 2012
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Will Uranium Ever Be a Buy? GuruFocusAug 29, 2016
Spectral Announces Normal Course Issuer Bid GuruFocusJul 05, 2016
FDA Accepts Spectral's Expanded Access Protocol for Toraymyxin(TM) GuruFocusJun 28, 2016
Spectral Medical Announces Acceptance of Pre-Clinical PMA Module for Toraymyxin(TM) by FDA GuruFocusJun 16, 2016
Spectral Commends Inclusion of Organ Dysfunction in New Expert Consensus Definitions of Sepsis ... GuruFocusMar 08, 2016
Spectral Approaches Finish Line for Clinical and Regulatory Program GuruFocusMar 02, 2016
Spectral and Toray Medical Sign Exclusive EAA(TM) Distribution Agreement for 15 Countries in ... GuruFocusOct 22, 2015
Body of Evidence Supporting the Use of Toraymyxin(TM) for Treatment of Septic Shock Continues ... GuruFocusOct 20, 2015
Spectral Now Recruiting the Last 75 Patients in Its Phase III Trial GuruFocusSep 15, 2015
Spectral on Track for Potential Commercialization in the First Half of 2016 GuruFocusJan 26, 2015
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Fastest Market News Application
You'll Hear It First On Pro

Login Register for Trial

Brokerage Center

Compare All Online Brokerages